OUR PUBLICATIONS 

arrow&v

2022

Vaccination rates in Europe are not associated with online media intensity

Luís C, Di Marzo VR, Kaur M, Argyropoulos CD, Devane D, Stewart FA, Antoniou G, Hendrickx G, Askling HH, Hellemans M, Cohen M, Spivak O, Van Damme P, Jane Cox R, Vene S, Sibia S, Pana ZD, Olesen OF, on behalf of VACCELERATE Consortium

Journal of Science Communication 21(05)(2022)A05

2022

Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children

Bougouma EC, Palacpac NMQ, Tiono AB, Nebie I, Ouédraogo A, Houard S, Yagi M, Coulibaly SA, Diarra A, Tougan T, Ouedraogo AZ, Soulama I, Arisue N, Yaro JB, D’Alessio F, Leroy O, Cousens S, Horii T, Sirima SB

Front. Immunol., 31 August 2022

2022

VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment

Salmanton-García J, Stewart FA, Heringer S, Koniordou M, Álvarez-Barco E, Argyropoulos CD, Themistocleous SC, Valle-Simón P, Spivak O, Součková L, Merakou C, Amélia Mendonça M, Joanna Davis R, Maria Azzini A, Askling HH, Vene S, Van Damme P, Steinbach A, Shiamakkides G, Seidel D, Olesen OF, Noula E, Macken A, Luís C, Leckler J, Launay O, Isitt C, Hellemans M, Frías-Iniesta J, Di Marzo R, Carcas AJ, Boustras G, Borobia AM, Barta I, Albus K, Akova M, Ochando J, Cohen-Kandli M, Jane Cox R, Husa P, Jancoriene L, Mallon P, Marques L, Mellinghoff SC, Nauclér P, Tacconelli E, Tóth K, Zaoutis TE, Zeitlinger M, Cornely OA, Pana ZD

Vaccine. 2022 Jul 29;40(31):4090-4097

2022

Asexual Blood-Stage Malaria Vaccine Candidate PfRipr5: Enhanced Production in Insect Cells

Correia R, Fernandes B, Castro R, Nagaoka H, Takashima E, Tsuboi T, Fukushima A, Viebig NK, Depraetere H, Alves PM, Roldão A.

Front Bioeng Biotechnol. 2022 Jun 30;10:908509

2022

Funders’ Perspectives on Supporting Implementation Research in Low- and Middle-Income Countries

Cardoso-Weinberg A, Alley C, Kupfer LE, Aslanyan G, Makanga M, Zicker F, Olesen OF

Glob Health Sci Pract. 2022;10(2):e2100497.

2022

A gaps-and-needs analysis of vaccine R&D in Europe: Recommendations to improve the research infrastructure

Jungbluth S, Depraetere H, Slezak M, Christensen D, Stockhofe N, Beloeil LA

Biologicals. 2022 Feb 26:S1045-1056(22)00017-3.

2021

Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain

Bekeredjian-Ding I, Trouvin JH, Depraetere H, La C, Suvarnapunya AE, Bell A, Mann A, Meij P, Bethony JM, Schellhaas L, Nazziwa WB, Karikari-Boateng E, Prachumsri JS, Salmikangas P, Smith D, Stjärnkvist P, Van Molle W, Baay M, Neels P

Biologicals. 2021 Nov;74:16-23.

2021

Accelerated phase Ia/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses

Remarque EJ, Faber BW, Rodriguez Garcia R, Oostermeijer H, Sirima SB, Ouedraogo IN, Kara L, Launay O, Houard S, Leroy O, and Kocken CHM

npj Vaccines 2021 6: 55

2021

Accelerated phase Ia/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses

Remarque EJ, Faber BW, Rodriguez Garcia R, Oostermeijer H, Sirima SB, Nebie Ouedraogo I, Kara L, Launay O, Houard S, Leroy O, Kocken CHM

NPJ Vaccines. 2021 Apr 14;6(1):55.

2021

Progress and Insights Toward an Effective Placental Malaria Vaccine

Gamain B, Chêne A, Viebig NK, Tuikue Ndam N, Nielsen MA.

Front Immunol. 2021 Feb 25;12:634508.